Ascendance Biotechnology Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 2
Employees
  • Latest Deal Type
  • M&A

Ascendance Biotechnology General Information

Description

Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include application-directed, cellular micro-patterning drug and chemical screening, predictive analysis and basic research, enabling pharmaceutical companies to get basic stem cell research through clinical manufacturing using products that are translatable to the clinic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Acquirer
IVT Holdings
Primary Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascendance Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Mar-2018 00000 Completed Generating Revenue
2. Angel (individual) 17-May-2016 00000 00000 Completed Startup
1. Angel (individual) 21-Dec-2015 $650K $650K Completed Startup
To view Ascendance Biotechnology’s complete valuation and funding history, request access »

Ascendance Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include appli
Biotechnology
Medford, MA
2 As of 2016
00000
000000&0 00000

00000000

ncididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullam
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
0000000000 0 000.00

00000000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000
Orlando, FL
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ascendance Biotechnology Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Formerly VC-backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
00000000 Accelerator/Incubator Backed Orlando, FL 00 000000000 -
00000000 Formerly VC-backed San Diego, CA 0 0000 000000&0
00 000000 Corporate Backed or Acquired Bridgewater, NJ 000000&0
000000 0000000000 Venture Capital-Backed Vancouver, Canada 00 000.00 00000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Ascendance Biotechnology Executive Team (2)

Name Title Board Seat Contact Info
Vincent Zurawski Ph.D Co-Founder, Chief Executive Officer & Board Member
Jeffrey Janus Co-Founder, President & Board Member
To view Ascendance Biotechnology’s complete executive team members history, request access »

Ascendance Biotechnology Board Members (6)

Name Representing Role Since
Jeffrey Janus Ascendance Biotechnology Co-Founder, President & Board Member 000 0000
Morton Collins Ph.D Self Board Member 000 0000
Robert Wilkins Ascendance Biotechnology Board Member 000 0000
Vincent Zurawski Ph.D Ascendance Biotechnology Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Ascendance Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascendance Biotechnology Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AgeX Therapeutics Corporation Minority 000 0000 000000 0
To view Ascendance Biotechnology’s complete investors history, request access »

Ascendance Biotechnology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 06-Nov-2015 000000 00 000000 Biotechnology
To view Ascendance Biotechnology’s complete acquisitions history, request access »